Daewoong/Novartis promise to cooperate

in the unused inventory return

Pharmaceutical Association "have a meeting and discuss, continue to request cooperation from pharmaceutical companies in March"

On the 22nd, the Korea Pharmaceutical Association (Chairman Choi Kwang-Hoon) disused stock medicine return TF (Team Leader Jung Hyeon-cheol) held a meeting with Daewoong Pharmaceutical and Novartis Korea regarding the return of unused stock medicine and announced that they had agreed to actively cooperate in a settlement.

 

In the case of Daewoong Pharmaceutical, through a meeting with the pharmaceutical society, wholesale shipments are 100%, returns are collected from base logistics within 1 month after being received, the balance is deducted for the settlement method, and a separate settlement rate is deducted for other return processing conditions.

 

It was confirmed that there is no criterion.

 

In addition, at the meeting with the Pharmacy Association, Novartis Korea explained that the return of unused medicines in stock is carried out only when the Pharmacy Association returns business is implemented, and regarding the practice guidelines for return work, 100% of the wholesale shipment price is collected in the reverse order of wholesale transactions, and the settlement method is warehousing.

 

Explained how to deduct the balance within 3 months after The Pharmaceutical Association said at this meeting that these pharmaceutical companies explained that there were some setbacks due to the fact that the contents of the Pharmacy Returns Project were not clearly communicated to practitioners.

 

The pharmacist association agreed to increase contact with pharmaceutical companies in the future and seek ways to coexist at the same time and explained that through this meeting, they had a meaningful time listening to pharmaceutical companies' difficulties related to the promotion of the pharmacists' return business and discussing solutions.

 

Jeong Hyeon-cheol, head of the return TF team, said, “We will continue to hold meetings with pharmaceutical companies that have not participated in the return business in March to do our best to achieve the best results among all unused inventory drug return businesses.” Team leader Jeong also said, “The unwanted inventory drug return TF will continue to cooperate with pharmaceutical companies and distributors so that all returns from pharmacies can be collected without a hitch by the end of March, and settlement can be made sequentially from April.” said.

 

Meanwhile, through this meeting, 143 pharmaceutical companies agreed to cooperate with the pharmacist association's return business, and 102 pharmaceutical companies confirmed detailed guidelines such as settlement rates.

 

The association plans to provide related data to local branches or distribution associations at the end of this month, along with interim aggregated data for entering pharmacy returns.